Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.

EA, DeFranco; JM, O'Brien; CD, Adair; DF, Lewis; DR, Hall; S, Fusey; P, Soma-Pillay; K, Porter; H, How; R, Schakis; D, Eller; Y, Trivedi; G, Vanburen; M, Khandelwal; K, Trofatter; D, Vidyadhari; J, Vijayaraghavan; J, Weeks; B, Dattel; E, Newton; C, Chazotte; G, Valenzuela; P, Calda; M, Bsharat; GW, Creasy

doi:10.1002/uog.5159

Public

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.

Shared by NobleBlocks on Oct 1, 2007 • 12:00 AM UTC

Authors:

DeFranco EA

O'Brien JM

Adair CD

Abstract

Objective To investigate the efficacy of vaginal progesterone to prevent early preterm birth in women with sonographic evidence of a short cervical length in the midtrimester.Methods This was a planned, but modified, secondary analysis of our multinational, multicenter, randomized, placebo-controlle...

Discussions